John Groetelaars
Fortune : 106 582 $ au 31/05/2026
Fortune : 106 582 $ au 31/05/2026
John P.
Groetelaars is currently Chief Executive Officer at Advanced Respiratory, Inc. He is Chairman at Zeus Industrial Products, Inc. since 2024.
He serves as Independent Director at PAREXEL International Corp.
since 2023 and at Medtronic Plc starting in 2025.
He is also a Venture Partner at Arboretum Ventures LLC since 2023.
Formerly, Mr. Groetelaars was President, Chief Executive Officer & Director at Hill-Rom Holdings, Inc. from 2018 to 2021.
He was Independent Non-Executive Director at Dentsply Sirona, Inc. from 2022 to 2023.
He served as Group Vice President at C.
R.
Bard, Inc. (New Jersey) from 2015 to 2017.
He was President & Executive Vice President at Becton, Dickinson & Co. from 2017 to 2018.
He held the position of General Manager & VP-UK, Ireland & Nordic Regions at Boston Scientific Corp.
from 2001 to 2008.
Other former roles include Director at Advanced Medical Technology Association, VP-Cardiac Surgery Marketing at Guidant Corp., President at Davol, Inc., and various titles at other firms.
Education includes an MBA from Columbia Business School conferred in 1991, an MBA from The Trustees of Columbia University in The City of New York, and undergraduate studies at Kettering University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 1 444 ( 0 % ) | 106 582 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Directeur/Membre du Conseil | 23/06/2023 |
| MEDTRONIC PLC | Directeur/Membre du Conseil | 19/08/2025 |
Advanced Respiratory, Inc.
Advanced Respiratory, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes non-invasive airway clearance products and systems | Directeur Général | - |
Arboretum Ventures LLC
Arboretum Ventures LLC Investment ManagersFinance Arboretum Ventures invests in companies located in the United States. The firm focuses on medical devices, diagnostics, healthcare IT and healthcare services sectors. It participates in seed and early-stage capital requirements with an investment size of USD 10 - 15 million. | Private Equity Investor | 01/01/2023 |
Zeus Industrial Products, Inc.
Zeus Industrial Products, Inc. Miscellaneous ManufacturingProducer Manufacturing Manufactures precision polymer extrusions and custom tubing | Président | 01/01/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| DENTSPLY SIRONA INC. | Directeur Général | 12/09/2022 |
| HILL-ROM HOLDINGS, INC. | Directeur Général | - |
| BECTON, DICKINSON AND COMPANY | President | 01/04/2018 |
| C.R. BARD | Corporate Officer/Principal | 01/01/2017 |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
C. R. Bard, Inc. (New Jersey)
C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology Designs, manufactures, packages, distributes and sells medical, surgical, diagnostic & patient care devices | Health Technology |
Becton, Dickinson & Co.
Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Hill-Rom Holdings, Inc.
Hill-Rom Holdings, Inc. Medical SpecialtiesHealth Technology Develops diagnostic cardiology devices and patient monitoring software & provides primary and home health care services | Health Technology |
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Davol, Inc.
Davol, Inc. Medical SpecialtiesHealth Technology Manufactures medical and surgical instruments | Health Technology |
Advanced Respiratory, Inc.
Advanced Respiratory, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes non-invasive airway clearance products and systems | Health Technology |
Kettering University
Kettering University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced Medical Technology Association
Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Operates as a trade association that offers information on philanthropy, blood products, diagnostics, orthopedics, ophthalmic, wound care and disaster preparedness | Commercial Services |
Zeus Industrial Products, Inc.
Zeus Industrial Products, Inc. Miscellaneous ManufacturingProducer Manufacturing Manufactures precision polymer extrusions and custom tubing | Producer Manufacturing |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
Dentsply Sirona, Inc.
Dentsply Sirona, Inc. Medical SpecialtiesHealth Technology Designs, manufactures endodontic, restorative and preventive consumable products, implants & provides CAD/CAM solutions | Health Technology |
Arboretum Ventures LLC
Arboretum Ventures LLC Investment ManagersFinance Arboretum Ventures invests in companies located in the United States. The firm focuses on medical devices, diagnostics, healthcare IT and healthcare services sectors. It participates in seed and early-stage capital requirements with an investment size of USD 10 - 15 million. | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national